Latest round: IPO. Christopher Schaber is the President and CEO of Soligenix, a late clinical-stage biopharmaceutical company. Based in Waltham, MA.
Dr. Christopher Schaber is the President and CEO of Soligenix, a late clinical-stage biopharmaceutical company. He leads the company's efforts in developing drug therapies for rare diseases and unmet medical needs, including treatments for oral mucositis and cutaneous T-cell lymphoma, covering specialized biotherapeutics, oncology, inflammation, and public health solutions.
Full founder directory · Investor directory · Company funding database · Fundraising library